GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
Kenneth L. Scott(Dana-Farber Cancer Institute), Lynda Chin(American Productivity and Quality Center), Alexei Protopopov, Kwok‐Kin Wong(NYU Langone Health), Shujuan Chen(The University of Texas MD Anderson Cancer Center), Hans R. Widlund(Brigham and Women's Hospital), David L. Rimm(Yale University), Mei‐Chih Liang(Dana-Farber Cancer Institute), Sabin Dhakal, Tamar Y. Feinberg, Elena V. Ivanova(Massachusetts General Hospital), David E. Fisher(Massachusetts General Hospital), Abdel Saci(Harvard University), Min Wu(Anhui Normal University), Yonghong Xiao, Joyce C. Wu, Joseph Huang, Valsamo Anagnostou(Johns Hopkins University), Omar Kabbarah(System Biosciences (United States))
Cited by 353
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k